EA200701947A1 - EASY PHARMACEUTICAL WATER, THERAPEUTIC COMPOSITIONS, ITS CONTAINING, METHODS OF THEIR PRODUCTION AND APPLICATION - Google Patents

EASY PHARMACEUTICAL WATER, THERAPEUTIC COMPOSITIONS, ITS CONTAINING, METHODS OF THEIR PRODUCTION AND APPLICATION

Info

Publication number
EA200701947A1
EA200701947A1 EA200701947A EA200701947A EA200701947A1 EA 200701947 A1 EA200701947 A1 EA 200701947A1 EA 200701947 A EA200701947 A EA 200701947A EA 200701947 A EA200701947 A EA 200701947A EA 200701947 A1 EA200701947 A1 EA 200701947A1
Authority
EA
Eurasian Patent Office
Prior art keywords
production
pharmaceutical
hho
easy
methods
Prior art date
Application number
EA200701947A
Other languages
Russian (ru)
Other versions
EA012855B1 (en
Inventor
Игорь Анатольевич Помыткин
Сергей Павлович Соловьёв
Original Assignee
Вада Консалтинг Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вада Консалтинг Лимитед filed Critical Вада Консалтинг Лимитед
Publication of EA200701947A1 publication Critical patent/EA200701947A1/en
Publication of EA012855B1 publication Critical patent/EA012855B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Abstract

Данное изобретение относится к фармацевтической воде, содержащей в своем составе от 99,760 до 99,999 % легкого изотопологаHO и до 100 % остаточного количества изотопологовHO,HO,HHO,HHO,HHO,HO,HO иHO, для производства конечного продукта, промежуточных реагентов, а также аналитических процедур в фармацевтической промышленности. Более того, изобретение касается фармацевтических композиций, включающих в себя биологически активное средство и вышеназванную фармацевтическую воду, где указанное средство выбрано из группы: лекарственные препараты, физиологически активные пептиды, физиологически активные белки и нуклеиновые кислоты. Кроме того, изобретение касается способа применения биологически активного средства у млекопитающего, нуждающегося в этом, который включает этап применения названным млекопитающим вышеуказанной терапевтической композиции.This invention relates to pharmaceutical water containing from 99.760 to 99.999% of the light isotopologue HO and up to 100% of the residual amount of isotopologues HO, HO, HHO, HHO, HHO, HO, HO and HO, for the production of the final product, intermediate reagents, as well as analytical procedures in the pharmaceutical industry. Moreover, the invention relates to pharmaceutical compositions comprising a biologically active agent and the aforementioned pharmaceutical water, wherein said agent is selected from the group: drugs, physiologically active peptides, physiologically active proteins and nucleic acids. In addition, the invention relates to a method of using a biologically active agent in a mammal in need thereof, which comprises the step of using the aforementioned therapeutic composition by said mammal.

EA200701947A 2005-03-11 2005-03-11 Light pharmaceutical water, therapeutic compositions comprising thereof, methods for preparing thereof and use thereof EA012855B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2005/000105 WO2006098650A1 (en) 2005-03-11 2005-03-11 Light pharmaceutical water and therapeutic compositions and methods thereof

Publications (2)

Publication Number Publication Date
EA200701947A1 true EA200701947A1 (en) 2008-02-28
EA012855B1 EA012855B1 (en) 2009-12-30

Family

ID=35793058

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701947A EA012855B1 (en) 2005-03-11 2005-03-11 Light pharmaceutical water, therapeutic compositions comprising thereof, methods for preparing thereof and use thereof

Country Status (6)

Country Link
US (1) US20080118463A1 (en)
EP (1) EP1855699B1 (en)
JP (1) JP2008533003A (en)
CN (1) CN101146543A (en)
EA (1) EA012855B1 (en)
WO (1) WO2006098650A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101146448A (en) * 2005-03-11 2008-03-19 维达咨询有限公司 Compositions for disinfecting inanimate surfaces
JP2008533005A (en) * 2005-03-11 2008-08-21 ヴァーダ コンサルティング リミテッド Method for intradermal, transdermal or transmucosal delivery of biologically active substances
RU2275920C1 (en) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Method for treating patients for neoplasms
RU2301067C1 (en) * 2006-06-19 2007-06-20 Сергей Павлович Соловьев Remedy and method for stimulating human sexual activity
RU2482706C1 (en) * 2011-12-05 2013-05-27 Игорь Анатольевич Помыткин Therapeutic nutrition for dietary control of depression and anxious disorders and its application method
RU2481009C1 (en) * 2011-12-05 2013-05-10 Игорь Анатольевич Помыткин Dietary control of depression and anxious disorders, therapeutic nutrition and its application methods
HUP1200552A2 (en) * 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
US20150374745A1 (en) * 2014-06-30 2015-12-31 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
RU2612667C1 (en) * 2015-10-13 2017-03-13 Общество с ограниченной ответственностью "МТК Айсберг" Device for production of water with reduced heavy molecules content
PL3445456T3 (en) * 2016-04-18 2021-12-13 Medena Ag Cosmetic composition comprising water depleted in 2h and 18o isotops
WO2018209449A1 (en) * 2017-05-18 2018-11-22 Medena Ag Use of naturally glycosylated polyphenols as protective agents against the effects of ultraviolet irradiation
CN109705142A (en) * 2018-12-24 2019-05-03 常州红太阳药业有限公司 The preparation method of sulbactam

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2108570A (en) * 1933-06-27 1938-02-15 American Security And Trust Co Kinds of water and methods of producing them
CH428671A (en) * 1964-12-02 1967-01-31 Raffinage Cie Francaise Process for modifying the ratio of isotopes in oxygen in favor of heavy isotopes and installation for carrying out this process
US4139619A (en) * 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
USH269H (en) * 1985-03-11 1987-05-05 A. E. Staley Manufacturing Company Disinfectant and/or sanitizing cleaner compositions
US4847079A (en) * 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
HU208084B (en) * 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
WO2004056314A2 (en) * 2002-12-17 2004-07-08 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
US6984327B1 (en) * 2004-11-23 2006-01-10 Patterson James A System and method for separating heavy isotopes of hydrogen oxide from water
JP2008533005A (en) * 2005-03-11 2008-08-21 ヴァーダ コンサルティング リミテッド Method for intradermal, transdermal or transmucosal delivery of biologically active substances

Also Published As

Publication number Publication date
WO2006098650A1 (en) 2006-09-21
EP1855699B1 (en) 2012-08-15
EA012855B1 (en) 2009-12-30
CN101146543A (en) 2008-03-19
US20080118463A1 (en) 2008-05-22
JP2008533003A (en) 2008-08-21
EP1855699A1 (en) 2007-11-21

Similar Documents

Publication Publication Date Title
EA200701947A1 (en) EASY PHARMACEUTICAL WATER, THERAPEUTIC COMPOSITIONS, ITS CONTAINING, METHODS OF THEIR PRODUCTION AND APPLICATION
ME00356B (en) Novel peptides that bind to the erythropoietin receptor
EA200901129A1 (en) NUCLEIC ACIDS AND POLYPEPTIDES OF THE NEW RECEPTOR
NO20080122L (en) Mixture of diisononyl esters of 1,2-cyclodicarboxylic acids, processes for the preparation and use thereof
ECSP055910A (en) NEW CARBOXILIC ACIDS AND ITS ESTERS, MEDICATIONS CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION
DE60035337D1 (en) Human peptides / proteins that cause or cause the killing of cells, including lymphoid tumor cells
EA200870021A1 (en) HUMAN MONOCLONAL ANTIBODIES TO FUKOZIL-GM1 AND METHODS OF APPLICATION OF ANTI-FUKOSIL-GM1 ANTIBODIES
EP2581450A3 (en) Non-natural amino acid substituted polypeptides
BRPI0513681A (en) compositions comprising her2 antibody, method, pharmaceutical formulations, polypeptide, antibody and cancer treatment method
HRP20110320T1 (en) Binding molecules capable of neutralizing rabies virus and uses thereof
JP2015042159A (en) Macrocyclic peptide, production method thereof, and screening method using macrocyclic peptide library
ATE485304T1 (en) MUTEINS OF TEARLIPOCALIN AND METHOD FOR OBTAINING THEM
CL2008003004A1 (en) Anti-sclerostin antibody or its antigen-binding portion; polynucleotide that encodes it; vector; cell; production process; pharmaceutical composition comprising it; method of identifying cells and their use to treat bone disorders.
EA200970263A1 (en) FULLY HUMAN HIGH-PRODUCTIVE SYSTEM FOR OBTAINING IMPROVED ANTIBODIES AND PROTEINS
NO20082559L (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
BRPI0716680A2 (en) "compound, multimer, composition, method of affecting the activity of a target, complex, process of production of compound, method of production of a consecutive amino acid extension, process of production of a consecutive amino acid extension, process for production of a compound, method of producing a protein and polypeptide "
BRPI0508670A (en) modified bouganin proteins, cytotoxins and their methods and uses
BRPI0513959A (en) antibodies directed against beta-amyloid peptide, their pharmaceutical compositions, kit and methods of manufacture thereof
SI2542257T1 (en) Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
DE602005009978D1 (en) METHOD FOR PRODUCING TWO AND THREE-DIMENSIONAL POLYMER PRODUCTS
DE60232158D1 (en) LIPOPEPTIDE STEREOISOMERS, METHOD FOR THEIR PRODUCTION AND USEFUL INTERMEDIATE PRODUCTS
IL206157A (en) Type 1 pancreatic elastase protein, a nucleic acid molecule encoding the protein, a vector, a host cell, methods of producing the protein and a pharmaceutical composition comprising the protein and the use thereof
CY1110401T1 (en) PRODUCTION OF 1-PHENYLCOCARCAROXYLIC ACIDS FOR TREATMENT OF NEUROCOLOGICAL DISEASES
AR036154A1 (en) SPECIFIC ANTIBODIES OF CD44V6.
WO2014161370A1 (en) Protamine peptidomimetic, and pharmaceutically acceptable salts and use thereof

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ RU